
Loading, please wait...

Loading, please wait...

Hepatocellular carcinoma (HCC) remains a significant clinical challenge in India due to late-stage diagnosis and metabolic flexibility. Recent findings demonstrate that TRIB3 HCC metabolic adaptation serves as a critical survival mechanism when glutamine levels are low. Researchers discovered that TRIB3, a pseudokinase, acts as a nuclear safeguard for DNA repair fidelity during nutrient stress.
Furthermore, the study explains that glutamine deprivation triggers c-Jun-dependent upregulation of TRIB3. This protein subsequently binds to G-quadruplex DNA (G4-DNA) structures across the genome. Specifically, TRIB3 recruits the helicase DDX5 to resolve these complex structures. Consequently, this cooperative functional complex maintains the transcription of essential homologous recombination genes like BRCA1 and RAD51AP1.
Without the TRIB3-DDX5 complex, HCC cells suffer from exaggerated G4-DNA accumulation. This leads to replication catastrophe and heightened DNA damage. Therefore, researchers suggest that TRIB3 levels correlate directly with poor clinical outcomes. Additionally, in vivo experiments showed that silencing TRIB3 suppresses xenograft growth, particularly when combined with glutamine-deficient diets. Thus, targeting the TRIB3-DDX5-G4 axis offers a promising therapeutic strategy for TRIB3-high malignancies.
TRIB3 facilitates metabolic adaptation by recruiting DDX5 to resolve G-quadruplex DNA structures. This action ensures that DNA repair genes remain active, preventing genomic instability and replication catastrophe.
Depleting TRIB3 causes G-quadruplexes to accumulate, which blocks the transcription of repair genes like BRCA1. This leads to increased DNA damage and eventually triggers apoptosis in the cancer cells.
While targeting glutamine alone often fails due to resistance, combining it with TRIB3 inhibition may overcome this adaptive survival mechanism, making tumors more vulnerable to therapy.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional services. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research identifies the TRIB3-DDX5 axis as a vital mechanism for hepatocellular carcinoma survival by resolving G-quadruplexes during glutamine deprivat...
5 months ago

Personalized medicine requires novel reimbursement models. This review examines how indication-based and performance-based pricing schemes influence drug availability, patient equity, and health system sustainability across multi-indication therapies.
Today

A retrospective cohort study reveals that simulation-free vaginal cuff brachytherapy achieves low 5-year vaginal recurrence rates comparable to simulation-verified protocols in high-intermediate risk endometrial cancer, supporting streamlined radiation oncology workflows.
Today

A systematic review evaluates machine learning models predicting cardiovascular adverse events in cancer patients, highlighting XGBoost performance, calibration gaps, and validation needs.
Today

A breakthrough study reveals how the agricultural fungicide thiram disrupts hepatic and tibial calcium homeostasis through ER stress and IP3R1/VDAC1 hyperactivation, uncovering a critical liver-bone axis of systemic toxicity.
Today

A study in children with severe acute malnutrition reveals disordered pancreatic and gut hormone responses to nutrient stimulation, including elevated basal insulin and blunted postprandial surges. These findings emphasize the need for refined nutritional rehabilitation protocols to prevent metabolic complications.
Today